The Chemo Concession Persists - Part II

The authors chose to focus on lung cancer because of the various treatment options, some of which are considerably more expensive than others. They found that doctors frequently switched drugs to choose the more expensive options. There was, for instance, an increased use of docetaxel (Taxotere), a drug for which oncologist get reimbursed about $2,500 per patient per month. http://www.cancerdecisions.com/content/view/526/2/lang,english/ Part 2
http://www.cancerdecisions.com/content/view/525/2/lang,english/ Part 1